Breast Cancer | Specialty

The OncLive Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.


Dr. O'Shaughnessy on the Future of Breast Cancer

September 9th 2011

Dr. Joyce A. O'Shaughnessy from Baylor Sammons Cancer Center on the Future of Breast Cancer Treatment

Dr. McDonald on Resistance to Angiogenesis Inhibitors

September 8th 2011

Dr. Donald M. McDonald from the UCSF Cancer Center Discusses Resistance to Angiogenesis Inhibitors

Dr. Dixon on Advances in Axillary Node Procedures

September 8th 2011

Dr. J. Michael Dixon from the University of Edinburgh on Advances in Breast Cancer Axillary Node Procedures

Breast Cancer Study Supports Role of Mammography, Self-Exams

September 7th 2011

Detecting breast cancer using mammography and self-examination was affirmed in a study that sharply contrasts the controversial 2009 USPSTF recommendations.

Dr. Rugo on Anti-Angiogenesis Therapy Response Predictors

September 7th 2011

Dr. Hope S. Rugo from University of California, San Francisco on Anti-Angiogenesis Therapy Response Predictors

New Nomogram Tools Predict Risk of Lymphedema

September 6th 2011

A new set of statistical models will soon be available to help predict the risk of lymphedema for patients with breast cancer who have undergone ALND.

Breast-Conserving Therapy Outcomes Deemed Similar to Mastectomy

September 6th 2011

Women age 40 and younger with breast cancer experience similar outcomes in local recurrence and survival rates whether they undergo BCT or a mastectomy.

Dr. Dixon Discusses Advances in Breast Cancer Treatment

September 6th 2011

Dr. J. Michael Dixon from the University of Edinburgh Discusses Advances in Breast Cancer Treatment

Dr. Ellis on Measuring Endocrine Therapy Efficacy

September 6th 2011

Dr. Matthew J. Ellis from Washington University on Measuring Endocrine Therapy Efficacy With Ki67

Conference Corner: 2 Upcoming Physicians' Education Resource Conferences

August 31st 2011

The 2 upcoming conferences include the 7th Annual Multidisciplinary Symposium on Head and Neck Cancer and the School of Breast Oncology.

Dr. Ellis on Ki67 as Treatment Monitoring Biomarkers

August 31st 2011

Dr. Matthew J. Ellis from Washington University Discusses Ki67 as a Treatment Monitoring Biomarker

Dr. O'Shaughnessy on Breast Cancer Biomarkers

August 30th 2011

Dr. Joyce A. O'Shaughnessy from Baylor Sammons Cancer Center on the Future of Breast Cancer Biomarkers

10 Tips for Breast Cancer Screening and Early Detection

August 29th 2011

Early detection offers the best chance for a cure.

Dr. Ellis Discusses the Future of the PI3-Kinase Pathway

August 26th 2011

Dr. Matthew J. Ellis from Washington University Discusses the Future of the PI3-Kinase Pathway

ASCO 2011: What Nurses Need to Know

August 26th 2011

Personal perspectives from oncology nurses of abstracts presented at ASCO on research with the potential to change practice, important studies that failed to meet expectations, and topics particularly relevant to oncology nurses.

Flaxseed Ineffective in Controlling Hot Flashes

August 25th 2011

Flaxseed had no effect on reducing hot flashes in postmenopausal women who reported experiencing 28 or more hot flashes per week.

Dr. Tripathy on Determining the Best HER2 Targeted Therapy

August 25th 2011

Dr. Debu Tripathy from USC Norris Cancer Center on Determining the Best HER2 Targeted Therapy

Dr. Ellis Discusses the Cell-Proliferation Marker Ki67

August 24th 2011

Dr. Matthew Ellis from Washington University Discusses the Cell-Proliferation Marker Ki67

Racing Against Breast Cancer: A Conversation With Edith A. Perez, MD

August 24th 2011

It's hard to tell which moves more quickly: Edith Perez's feet, or her mind.

ASCO Highlights: Trials in Progress

August 23rd 2011

The following is a roundup of TPS abstracts that feature trials open to patients aged >17 years with a broad range of cancer types.